Physician profile
Michael Bryant
NPI 1558688648
$4,669.59
in general payments reported to CMS, 2019-2025
41 companies · $599 in 2025
The $599 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $918 · 2020: $427 · 2021: $199 · 2022: $953 · 2023: $882 · 2024: $692 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,173.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $811.72 | 2019-2025 | Lithovue, Spaceoar Vue System - 10ml, Rezum Generator |
| Teleflex LLC | $332.31 | 2023 | Urolift |
| Sumitomo Pharma America, INC. | $320.87 | 2023-2025 | Orgovyx, Gemtesa |
| Astellas Pharma US INC | $294.67 | 2019-2024 | Xtandi |
| Dendreon Pharmaceuticals LLC | $210.52 | 2019-2024 | Provenge |
| Procept Biorobotics Corporation | $195.17 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Endo Pharmaceuticals INC. | $192.57 | 2019-2024 | Xiaflex, Aveed |
| Myovant Sciences INC. | $188.53 | 2021-2022 | |
| Olympus America INC. | $177.70 | 2020-2022 | |
| Janssen Biotech, INC. | $176.82 | 2019-2024 | Erleada |
| Accord Healthcare, INC. | $144.50 | 2022 | |
| Laborie Medical Technologies Corp. | $139.95 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Pfizer INC. | $115.91 | 2020-2025 | |
| Blue Earth Diagnostics | $112.78 | 2019-2022 | |
| Abbvie INC. | $104.13 | 2019-2025 | Lupron Depot |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $97.52 | 2019 | |
| Ferring Pharmaceuticals INC. | $94.29 | 2019-2025 | Adstiladrin |
| Calyxo, INC. | $90.79 | 2024-2025 | Cvac Aspiration System |
| Myriad Genetic Laboratories, INC. | $70.69 | 2022-2025 | Prolaris |
| Stryker Corporation | $68.00 | 2022 | |
| Neotract INC. | $65.53 | 2019-2020 | |
| Therapeuticsmd, INC. | $63.68 | 2019 | |
| Merck Sharp & Dohme LLC | $60.73 | 2024 | Welireg, Keytruda |
| Urogen Pharma, INC. | $58.85 | 2024-2025 | |
| Ambu INC. | $55.22 | 2021-2024 | |
| Edap Technomed INC | $54.00 | 2024 | |
| Coloplast Corp | $53.38 | 2023-2025 | Speedicath |
| C. R. Bard, INC. & Subsidiaries | $40.68 | 2022 | |
| Innovation Technologies INC | $38.74 | 2024-2025 | Irrisept |
| 180 Medical, INC. | $29.43 | 2021 | |
| Amgen INC. | $25.54 | 2020 | |
| Dentsply Ih Ab | $24.18 | 2025 | Lofric |
| Axonics, INC. | $21.80 | 2023 | Bulkamid, Axonics |
| Karl Storz Endoscopy-America | $21.45 | 2022 | |
| Agiliti Surgical, INC. | $21.25 | 2023 | Trinity, Soltive, Sonablate |
| Antares Pharma, INC. | $20.07 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.12 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.73 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.34 | 2023 | |
| Travere Therapeutics, INC. | $13.95 | 2020-2021 | |
| Metuchen Pharmaceuticals | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.